|
CCDC14 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.962390E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.702400E-01 |
| Normal-vs-Stage2 |
5.500600E-03 |
| Normal-vs-Stage3 |
5.480400E-02 |
| Normal-vs-Stage4 |
9.586800E-01 |
| Stage1-vs-Stage2 |
8.817100E-03 |
| Stage1-vs-Stage3 |
5.977700E-02 |
| Stage1-vs-Stage4 |
8.084000E-01 |
| Stage2-vs-Stage3 |
1.650030E-01 |
| Stage2-vs-Stage4 |
6.840000E-02 |
| Stage3-vs-Stage4 |
2.754200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.199600E-01 |
| Normal-vs-AfricanAmerican |
5.950200E-01 |
| Normal-vs-Asian |
9.142100E-02 |
| Caucasian-vs-AfricanAmerican |
8.424800E-01 |
| Caucasian-vs-Asian |
6.085000E-03 |
| AfricanAmerican-vs-Asian |
1.017200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.204800E-01 |
| Normal-vs-Female |
1.042830E-01 |
| Male-vs-Female |
2.157000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.733200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.428640E-01 |
| Normal-vs-Age(61-80Yrs) |
1.438800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.590400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.807600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.526400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.920200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.000200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.325800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.706200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.060380E-03 |
| Classical-VS-Follicular |
1.260010E-02 |
| Classical-VS-Other |
4.852600E-01 |
| Classical-VS-Normal |
8.244000E-01 |
| Tall-VS-Follicular |
6.533600E-01 |
| Tall-VS-Other |
2.006200E-01 |
| Tall-VS-Normal |
4.821700E-03 |
| Follicular-VS-Other |
8.267800E-02 |
| Follicular-VS-Normal |
2.868100E-02 |
| Other-VS-Normal |
5.178600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.708100E-02 |
| Normal-vs-N1 |
1.377780E-01 |
| N0-vs-N1 |
1.172240E-02 |
|
|
